Investigating factors that contribute to resistance in breast cancer treatment
Targeting secreted factors in endocrine resistant breast cancer therapy
This study is looking at how some breast cancer cells talk to the surrounding tissue, especially when they stop responding to regular hormone treatments, to find new ways to help patients get better.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albany College of Pharmacy NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project ID | NIH-10654343 on NIH RePORTER |
What this research studies
This research focuses on understanding how certain breast cancer cells communicate with surrounding tissue, particularly in cases where the cancer has become resistant to standard hormone therapies. By studying specific proteins and factors involved in this communication, the researchers aim to uncover mechanisms that allow cancer cells to thrive despite treatment. The project involves creating and analyzing different breast cancer cell lines to identify key factors that could be targeted for new therapies. Ultimately, the goal is to develop strategies that can block harmful interactions between cancer cells and their environment, potentially leading to more effective treatments for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are postmenopausal women with early-stage breast cancer who have developed resistance to endocrine therapies.
Not a fit: Patients with non-endocrine resistant breast cancer or those not undergoing endocrine therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve outcomes for patients with endocrine-resistant breast cancer.
How similar studies have performed: Previous research has shown promise in targeting communication pathways in cancer, suggesting that this approach could yield valuable insights and potential breakthroughs.
Where this research is happening
Albany, United States
- Albany College of Pharmacy — Albany, United States (Active)
Researchers
- Principal investigator: Jin, Kideok — Albany College of Pharmacy
- Study coordinator: Jin, Kideok
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.